BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36351894)

  • 1. PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.
    Liao Y; Luo Z; Lin Y; Chen H; Chen T; Xu L; Orgurek S; Berry K; Dzieciatkowska M; Reisz JA; D'Alessandro A; Zhou W; Lu QR
    Cell Death Dis; 2022 Nov; 13(11):943. PubMed ID: 36351894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
    Lei Y; Han P; Chen Y; Wang H; Wang S; Wang M; Liu J; Yan W; Tian D; Liu M
    Clin Transl Med; 2022 Jan; 12(1):e686. PubMed ID: 35090076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin.
    Peng G; Wang Y; Ge P; Bailey C; Zhang P; Zhang D; Meng Z; Qi C; Chen Q; Chen J; Niu J; Zheng P; Liu Y; Liu Y
    J Exp Clin Cancer Res; 2021 Sep; 40(1):278. PubMed ID: 34470658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased nitric oxide content mediated by asymmetrical dimethylarginine and protein l-arginine methyltransferase 3 in macrophages induces trophoblast apoptosis: a potential cause of recurrent miscarriage.
    Hao F; Tang LC; Sun JX; Li WX; Zhao Y; Xu XH; Jin LP
    Hum Reprod; 2021 Nov; 36(12):3049-3061. PubMed ID: 34647126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.
    Wang Y; Wang C; Guan X; Ma Y; Zhang S; Li F; Yin Y; Sun Z; Chen X; Yin H
    Adv Sci (Weinh); 2023 Dec; 10(36):e2303812. PubMed ID: 37973560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648.
    Min Z; Xiaomeng L; Zheng L; Yangge D; Xuejiao L; Longwei L; Xiao Z; Yunsong L; Ping Z; Yongsheng Z
    Cell Death Dis; 2019 Aug; 10(8):581. PubMed ID: 31378783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers.
    Hsu SH; Hung WC
    Cancer Lett; 2023 Feb; 554():216008. PubMed ID: 36400311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
    Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
    PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.
    Liao Z; She C; Ma L; Sun Z; Li P; Zhang X; Wang P; Li W
    Cell Mol Neurobiol; 2019 Nov; 39(8):1207-1215. PubMed ID: 31342232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
    Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
    Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
    Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
    Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
    Shukla A; Srivastava S; Darokar J; Kulshreshtha R
    Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
    Polson ES; Kuchler VB; Abbosh C; Ross EM; Mathew RK; Beard HA; da Silva B; Holding AN; Ballereau S; Chuntharpursat-Bon E; Williams J; Griffiths HBS; Shao H; Patel A; Davies AJ; Droop A; Chumas P; Short SC; Lorger M; Gestwicki JE; Roberts LD; Bon RS; Allison SJ; Zhu S; Markowetz F; Wurdak H
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.
    Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG
    Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.